Allergan Strikes $200M Deal To Exit NY Opioid Trial

By Cara Salvatore · December 8, 2021, 11:11 AM EST

Allergan has reached a settlement worth up to $200 million to end its participation in a closely watched New York opioid trial brought by state and county governments, according to a Wednesday announcement....

To view the full article, register now.

Try a seven day FREE Trial

Already a subscriber? Click here to login

Case Information

Case Title

In Re: National Prescription Opiate Litigation

Case Number

Court

Ohio Northern

Nature of Suit

P.I.: Other

Date Filed

November 04, 2022

Recent Articles By Cara

October 31, 2024
Abbott, Mead Cleared In Baby Formula Trial
October 30, 2024
Jury Told Abbott, Mead Owe 'Astronomical' Sum Over Formula
October 25, 2024
Jury In Formula Trial Told Baby's Condition Likely Genetic
August 23, 2024
Ex-Exec Can't Reverse Medtronic Insider Trading Conviction
July 26, 2024
Abbott Owes $495M In Baby Formula Bellwether Trial
January 12, 2024
How A 'Graphic' Trial Sparked A Juror Mental Health Movement
January 01, 2024
Trials To Watch In 2024
December 19, 2023
Error-Filled Employment Trial Transcript Replaced By Judge
November 29, 2023
How New Expert-Witness Rules Put Science Front And Center
September 15, 2023
Split Ill. Appellate Panel Affirms $49M Med Mal Win